PT4005588T - Composição para estimulação controlada do ovário - Google Patents

Composição para estimulação controlada do ovário

Info

Publication number
PT4005588T
PT4005588T PT212077176T PT21207717T PT4005588T PT 4005588 T PT4005588 T PT 4005588T PT 212077176 T PT212077176 T PT 212077176T PT 21207717 T PT21207717 T PT 21207717T PT 4005588 T PT4005588 T PT 4005588T
Authority
PT
Portugal
Prior art keywords
composition
ovarian stimulation
controlled ovarian
controlled
stimulation
Prior art date
Application number
PT212077176T
Other languages
English (en)
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46785372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT4005588(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of PT4005588T publication Critical patent/PT4005588T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT212077176T 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário PT4005588T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11176803 2011-08-08

Publications (1)

Publication Number Publication Date
PT4005588T true PT4005588T (pt) 2024-04-24

Family

ID=46785372

Family Applications (6)

Application Number Title Priority Date Filing Date
PT14184409T PT2821080T (pt) 2011-08-08 2012-08-08 Composição para simulação de ovário controlada
PT201869351T PT3756681T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT212077176T PT4005588T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT17154031T PT3195875T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT192136497T PT3646881T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT18167552T PT3395357T (pt) 2011-08-08 2012-08-08 Composição para simulação de ovário controlada

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PT14184409T PT2821080T (pt) 2011-08-08 2012-08-08 Composição para simulação de ovário controlada
PT201869351T PT3756681T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário

Family Applications After (3)

Application Number Title Priority Date Filing Date
PT17154031T PT3195875T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT192136497T PT3646881T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT18167552T PT3395357T (pt) 2011-08-08 2012-08-08 Composição para simulação de ovário controlada

Country Status (31)

Country Link
US (4) US9694052B2 (pt)
EP (9) EP4005588B1 (pt)
JP (5) JP6161609B2 (pt)
KR (7) KR102111514B1 (pt)
CN (2) CN103732243A (pt)
AR (1) AR087476A1 (pt)
AU (3) AU2012293647B2 (pt)
BR (2) BR112014002884A2 (pt)
CA (1) CA2844282A1 (pt)
CY (1) CY1117214T1 (pt)
DK (8) DK2821080T3 (pt)
ES (7) ES2692774T3 (pt)
FI (2) FI3756681T3 (pt)
HK (2) HK1198005A1 (pt)
HR (7) HRP20230607T1 (pt)
HU (7) HUE041769T2 (pt)
IL (2) IL300380A (pt)
JO (1) JO3092B1 (pt)
LT (7) LT4005588T (pt)
MX (2) MX348981B (pt)
PL (7) PL2821080T3 (pt)
PT (6) PT2821080T (pt)
RS (7) RS64328B1 (pt)
RU (2) RU2613324C3 (pt)
SA (1) SA112330762B1 (pt)
SI (7) SI3756681T1 (pt)
SM (1) SMT201600038B (pt)
TR (2) TR201911269T4 (pt)
TW (2) TWI657822B (pt)
WO (1) WO2013020996A1 (pt)
ZA (2) ZA201400952B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
CN107429237B (zh) * 2014-12-22 2021-09-28 豪夫迈·罗氏有限公司 Cmp依赖性的唾液酸酶活性
RU2704252C2 (ru) * 2015-04-17 2019-10-25 Ферринг Б.В. Композиция для лечения бесплодия
MY179524A (en) 2015-06-26 2020-11-10 Ferring Bv Methods of purification and/or viral inactivation
MX2018002921A (es) * 2015-09-17 2018-12-10 Glycotope Gmbh Composicion de hormona foliculo-estimulante mamifera con estabilidad incrementada.
CA3038865A1 (en) * 2016-09-30 2018-04-05 Myovant Sciences Gmbh Methods of treating female infertility
CA3073624A1 (en) 2017-09-01 2019-03-07 Ferring B.V. Composition for controlled ovarian stimulation
EP3787667A1 (en) * 2018-04-30 2021-03-10 Ferring B.V. Composition for controlled ovarian stimulation
TW202027780A (zh) 2018-10-17 2020-08-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
CN110841060A (zh) * 2019-11-21 2020-02-28 上海交通大学 Choriogonadotropin alfa在治疗多囊卵巢综合征中的应用
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
WO2023186331A1 (en) 2022-04-01 2023-10-05 Ferring B.V. Mixed protocol for treatment of infertility
WO2023227761A1 (en) 2022-05-26 2023-11-30 Ferring B.V. Compositions and methods for treatment of infertility in males
WO2024008971A1 (en) 2022-07-08 2024-01-11 Ferring B.V. Compositions and methods for intrauterine insemination (iui)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW518235B (en) 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
EP1074265A1 (en) * 1999-08-03 2001-02-07 Erasmus Universiteit Rotterdam Use of AMH and/or AMH agonists and/or AMH antagonists for long-term control of female fertility
AU2002340562B2 (en) * 2001-10-22 2008-10-23 Merck Serono Sa Compositions of FSH with high sialylation degree and their use for the preparation of medicaments
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US8501719B2 (en) * 2005-11-08 2013-08-06 American Infertility Of New York Androgen treatment in females
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
EP2842567A1 (en) * 2010-09-29 2015-03-04 Ferring B.V. Composition for controlled ovarian stimulation
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
JP2023134561A (ja) 2023-09-27
WO2013020996A1 (en) 2013-02-14
IL300380A (en) 2023-04-01
LT3195875T (lt) 2018-11-12
EP3195875B1 (en) 2018-07-25
RU2613324C2 (ru) 2017-03-15
KR20230024442A (ko) 2023-02-20
RS58198B1 (sr) 2019-03-29
ES2950911T3 (es) 2023-10-16
JP2019077693A (ja) 2019-05-23
HUE041769T2 (hu) 2019-05-28
MX2020010991A (es) 2020-11-09
KR20140054191A (ko) 2014-05-08
RS64328B1 (sr) 2023-08-31
US20220370567A1 (en) 2022-11-24
KR102499969B1 (ko) 2023-02-14
ES2871405T3 (es) 2021-10-28
TR201911269T4 (tr) 2019-08-21
LT4005588T (lt) 2024-03-25
JP6500050B2 (ja) 2019-04-10
HUE053716T2 (hu) 2021-07-28
DK3756681T3 (da) 2023-07-31
MX2014001489A (es) 2014-04-25
RS61843B1 (sr) 2021-06-30
EP3566712B1 (en) 2021-01-27
HRP20210722T1 (hr) 2021-06-11
RU2014102924A (ru) 2015-09-20
KR20200121918A (ko) 2020-10-26
KR20210099162A (ko) 2021-08-11
EP4005588B1 (en) 2024-02-07
EP3756681A1 (en) 2020-12-30
RU2739037C3 (ru) 2021-09-08
ES2742163T3 (es) 2020-02-13
RU2017106756A3 (pt) 2020-07-09
IL230696A0 (en) 2014-03-31
DK4005588T3 (da) 2024-04-29
US10624953B2 (en) 2020-04-21
ZA201506382B (en) 2017-01-25
TWI657822B (zh) 2019-05-01
AU2018203222A1 (en) 2018-05-24
EP4306174A2 (en) 2024-01-17
JP7309660B2 (ja) 2023-07-18
HRP20230607T1 (hr) 2023-09-29
LT3395357T (lt) 2019-08-26
RS57897B1 (sr) 2019-01-31
EP3395357B1 (en) 2019-05-15
EP2741763B1 (en) 2015-11-18
EP3195875A1 (en) 2017-07-26
PL3566712T3 (pl) 2021-07-12
ES2884947T3 (es) 2021-12-13
IL230696B2 (en) 2023-07-01
FI3756681T3 (fi) 2023-07-28
KR102111514B1 (ko) 2020-05-18
MX348981B (es) 2017-07-06
LT2821080T (lt) 2019-01-10
DK3395357T3 (da) 2019-08-19
US9694052B2 (en) 2017-07-04
SI2821080T1 (sl) 2019-01-31
HRP20191437T1 (hr) 2019-11-15
SI3195875T1 (sl) 2018-11-30
CN107281470A (zh) 2017-10-24
SI3756681T1 (sl) 2023-08-31
SI3395357T1 (sl) 2019-09-30
JO3092B1 (ar) 2017-03-15
AU2018203222B2 (en) 2020-03-12
HRP20210277T1 (hr) 2021-04-02
DK2741763T3 (da) 2016-02-15
HK1204923A1 (en) 2015-12-11
CA2844282A1 (en) 2013-02-14
NZ620369A (en) 2015-12-24
JP2014522871A (ja) 2014-09-08
PL3395357T3 (pl) 2019-11-29
HUE040058T2 (hu) 2019-02-28
TW201716082A (zh) 2017-05-16
PL3195875T3 (pl) 2019-01-31
KR20210143934A (ko) 2021-11-29
US20200345814A1 (en) 2020-11-05
CY1117214T1 (el) 2017-04-05
PT3395357T (pt) 2019-08-27
FI4005588T3 (fi) 2024-05-15
HRP20181639T1 (hr) 2018-12-14
DK3646881T3 (da) 2021-07-26
EP3646881A1 (en) 2020-05-06
AU2016273925B2 (en) 2018-03-15
LT3646881T (lt) 2021-05-25
EP4005588A1 (en) 2022-06-01
SI2741763T1 (sl) 2016-02-29
IL230696B1 (en) 2023-03-01
EP4306174A3 (en) 2024-04-10
JP2020147600A (ja) 2020-09-17
HUE062640T2 (hu) 2023-11-28
DK3566712T3 (da) 2021-04-19
PT3646881T (pt) 2021-06-02
EP2741763A1 (en) 2014-06-18
EP2821080B1 (en) 2018-10-10
EP3646881B1 (en) 2021-04-28
TR201900071T4 (tr) 2019-01-21
RU2739037C2 (ru) 2020-12-21
KR102353144B1 (ko) 2022-01-18
AU2012293647B2 (en) 2016-10-06
DK2821080T3 (en) 2019-01-28
JP6718951B2 (ja) 2020-07-08
SI3646881T1 (sl) 2021-08-31
RU2017106756A (ru) 2019-01-23
BR122020001644B1 (pt) 2022-08-02
EP3566712A1 (en) 2019-11-13
EP3395357A1 (en) 2018-10-31
DK3195875T3 (en) 2018-11-12
EP3756681B1 (en) 2023-05-03
US20140329748A1 (en) 2014-11-06
ES2704878T3 (es) 2019-03-20
JP2017141253A (ja) 2017-08-17
SI3566712T1 (sl) 2021-04-30
RS54561B1 (en) 2016-06-30
HUE027674T2 (en) 2016-11-28
PL3756681T3 (pl) 2023-08-21
US11291708B2 (en) 2022-04-05
KR20190100449A (ko) 2019-08-28
HK1198005A1 (zh) 2015-03-06
PL3646881T3 (pl) 2021-11-02
AU2016273925A1 (en) 2017-01-12
LT3566712T (lt) 2021-03-10
RU2613324C3 (ru) 2021-06-09
KR20190140098A (ko) 2019-12-18
AU2012293647A1 (en) 2014-02-27
HRP20190023T1 (hr) 2019-02-22
ES2692774T3 (es) 2018-12-05
HRP20160145T1 (hr) 2016-04-08
RS61672B1 (sr) 2021-04-29
SMT201600038B (it) 2016-02-25
PL2821080T3 (pl) 2019-04-30
CN103732243A (zh) 2014-04-16
KR102014469B1 (ko) 2019-08-26
ZA201400952B (en) 2022-03-30
PT3195875T (pt) 2018-10-31
US20180028620A1 (en) 2018-02-01
PT3756681T (pt) 2023-07-25
AR087476A1 (es) 2014-03-26
HUE044610T2 (hu) 2019-11-28
TWI555530B (zh) 2016-11-01
LT3756681T (lt) 2023-07-25
JP6161609B2 (ja) 2017-07-12
TW201309322A (zh) 2013-03-01
EP2821080A1 (en) 2015-01-07
PT2821080T (pt) 2018-12-17
RS59107B1 (sr) 2019-09-30
SA112330762B1 (ar) 2015-10-08
BR112014002884A2 (pt) 2017-02-21
HUE054312T2 (hu) 2021-08-30
ES2562648T3 (es) 2016-03-07
PL2741763T3 (pl) 2016-07-29

Similar Documents

Publication Publication Date Title
HRP20190023T1 (hr) Pripravak za kontroliranu stimulaciju jajnika
PT3566712T (pt) Composição para estimulação controlada do ovário